NeuroLex EEG-Based ADHD Assessment Aid, Pivotal Study

Completed

Conditions studied: Attention Deficit Disorder With Hyperactivity

In brief

The study will evaluate the effectiveness of a standardized EEG method with the intended clinical users in the intended clinical settings with the intended population (patients who would typically receive a clinician's evaluation for ADHD). Multiple sites will be examined to provide a sample of patients across numerous communities with different demographics. The goal is to evaluate if the predictive accuracy of EEG will not be inferior to that of a widely-used and extensively validated ADHD scale in the prediction of ADHD in the intended use population as evaluated by Best Estimate Diagnosis.

Key facts

Study ID

NCT00595751

Run by

Lexicor Medical Technology, LLC

People needed

300

Starts

2007-12-01

Expected to finish

2008-06-01

Last updated by the study team

2008-07-30

Who can join

Age: 6 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject willing to voluntarily participate in a research study that includes EEG collection and analysis.
• Family/patient seeking comprehensive clinical evaluation for attention and/or behavior concerns.
• Male or female at least 6 years of age and who will not be over 17.99 years of age upon admission to study.
• Willing to stop any and all current psychiatric medications prior to or by entry into study.
• Subject and parent (or legal representative) of an educational level and degree of understanding sufficient to communicate suitably with the investigator, rater and study coordinator.

You may not qualify if…

• Previous diagnosis of mental retardation. IQ < 70 by previous records.
• History of seizure disorder or of EEG abnormalities. On anticonvulsants for seizure control.
• Metal plate or metal device in the head.
• Suicide ideation or gesture and/or homicidal ideation or gesture.
• Concomitant medications during participation in a research study. No prescription or nonprescription medications with psychoactive properties that may affect EEG (such as over-the-counter dietary supplements, pseudoephedrine, or phenylpropanolamine). No antipsychotics, no psychostimulants, no antidepressants. Washout of at least one week or longer depending on the medication and clinician's judgment. Medication used for medical reasons must be cleared by research staff with consideration of known effects on EEG.
• Known serious medical problems (cardiovascular, hematological, liver, seizure disorder, renal, or chronic respiratory problems).

Where it is running

• Harmonex — Dothan, Alabama, United States
• Indian Crest Pediatrics — Westminster, Colorado, United States
• Medical College of Georgia — Augusta, Georgia, United States
• Mercer University School of Medicine — Macon, Georgia, United States
• LSU, HSC — New Orleans, Louisiana, United States
• Children's Specialized Hospital — Toms River, New Jersey, United States
• SUNY Upstate Medical University — Syracuse, New York, United States
• Rakesh Ranjan, MD & Associates — Beachwood, Ohio, United States
• Eminence Research, LLC — Oklahoma City, Oklahoma, United States
• Oklahoma University Child Study Center — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.